Treatment of resected non-small-cell lung cancer [1] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 14, 2005, Pages 1523-1524

  Bria, Emilio ^a   Giannarelli, Diana ^a   Terzoli, Edmondo ^a   Winton, Timothy L ^b   Ding, Keyue ^c   Seymour, Lesley ^c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Institut national du cancer du Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSENSUS; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; META ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 25844434384     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc052019     Document Type: Letter

References (0)